Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 15/20 | 0.43 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | RHEB | Q15382 | 2/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | PRSS12 | P56730 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2361393 | 0.94 | PTGES (0.47) | PTGESJAK2CYP2C9CYP2D6DGAT1 | |
| SCHEMBL4785925 | 0.87 | PTGES (0.49) | PTGESJAK2CYP2C9MAPK14 | |
| SCHEMBL2360765 | 0.84 | NPBWR1 (0.48) | PTGESDGAT1 | |
| SCHEMBL2361558 | 0.83 | PTGES (0.53) | PTGESJAK2CYP2C9CYP2D6DGAT1 | |
| SCHEMBL2360673 | 0.82 | DGAT1 (0.56) | PTGESCYP2C9DGAT1MAPK14 | |
| SCHEMBL2361397 | 0.80 | DGAT1 (0.51) | PTGESDGAT1 | |
| SCHEMBL2361259 | 0.79 | PTGES (0.48) | PTGESJAK2CYP2C9CYP2D6DGAT1 | |
| SCHEMBL2360992 | 0.79 | PTGES (0.59) | PTGESJAK2 | |
| SCHEMBL2361320 | 0.79 | PTGES (0.47) | PTGESJAK2CYP2C9 | |
| SCHEMBL2364703 | 0.77 | PTGES (0.48) | PTGESJAK2CYP2C9CYP2D6DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011099832-A2 | NOVEL BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CRYSTALGENOMICS, INC. (KR) | 2011-08-18 | — | — | WO | disclosed |